CD4 and primary cutaneous T-cell non-Hodgkin lymphoma: A study by Wilcox et al. demonstrated PD-L1 expression in peripheral blood CD4+ T cells in the majority of patients with leukemic CTCL, however only in 27% of patients’ biopsies as evaluated with immunohistochemistry [186].